SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It is typically used alongside diet and exercise to support overall diabetes care. This medication is not intended for type 1 diabetes or diabetic ketoacidosis.

Common effects of Segluromet 7.5 mg/1 may include symptoms like nausea, diarrhea, or headache. Some users might experience urinary tract infections or low blood sugar, especially when combined with other diabetes medications.

Handle Segluromet 7.5 mg/1 with care, especially if you have kidney issues or are at risk of dehydration. Regular monitoring of blood sugar levels is recommended. Always follow your healthcare provider's guidance for safe usage.

Segluromet 7.5 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Alcohol can increase the risk of low blood sugar and should be avoided. Consult your healthcare provider before combining it with other treatments.